New Key Statistics Module, Z-Score and F-Score
NAS:SLNO Key Ratios
Market Cap $ M | 1,547.62 |
Enterprise Value $ M | 1,361.30 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 9.76 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -2.71 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 35.60 |
5-y EBITDA Growth Rate % | 26.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -25.85 |
EV-to-EBITDA | -26.83 |
PEG | -- |
Shares Outstanding M | 36.86 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 11.23 |
Current Ratio | 11.23 |
ROA % (ttm) | -56.12 |
ROE % (ttm) | -76.70 |
ROIC % (ttm) | -292.49 |
Dividend Yield % | -- |
Altman Z-Score | -- |
SLNO Number of Guru Trades
SLNO Volume of Guru Trades
Gurus Latest Trades with NAS:SLNO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SLNO is held by these investors
Total 2
Soleno Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SLNO
Total 0- 1